Dong-A Socio Holdings corrects subsidiary name on KRW 7.54 billion drug contract filing
The company issued a correction to its April 20 disclosure, revising subsidiary name to BTGen from STGenBio and extending the confidentiality hold deadline to Oct. 7, 2029.